Gary A. Cameron
Impact in
-
- Circadian rhythm and melatonin
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
Papers in
-
- Cannabis and Cannabinoid Research 4
- Inflammatory mediators and NSAID effects 3
- Pharmacogenetics and Drug Metabolism 2
-
- Redox biology and oxidative stress 2
- Co-authors
- Lorna Aucott (1 shared paper)Nigel R. Webster (1 shared paper)Helen F. Galley (1 shared paper)Damon A. Lowes (1 shared paper)Gabrielle Hawksworth (5 shared papers)James S. McLay (5 shared papers)Lucy J. Elrick (2 shared papers)Matthew C. Wright (2 shared papers)
- Journals
- PLoS ONE (3 papers)Toxicology (2 papers)Nature Communications (1 paper)Pharmaceutics (1 paper)Hepatology (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Gary A. Cameron
24 papers receiving 725 citations
Peers
Comparison fields: 5 of 108
- Endocrine and Autonomic Systems 102
- Pharmacology 223
- Hepatology 58
- Biological Psychiatry 17
- Cellular and Molecular Neuroscience 90
Countries citing papers authored by Gary A. Cameron
This map shows the geographic impact of Gary A. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Cameron more than expected).
Fields of papers citing papers by Gary A. Cameron
This network shows the impact of papers produced by Gary A. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Cameron. The network helps show where Gary A. Cameron may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary A. Cameron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 132 | |
| 2 | 2010 | 91 | |
| 3 | 2011 | 61 | |
| 4 | 2014 | 57 | |
| 5 | 2004 | 57 | |
| 6 | 2015 | 56 | |
| 7 | 2010 | 49 | |
| 8 | 2003 | 40 | |
| 9 | 2015 | 36 | |
| 10 | 1991 | 31 | |
| 11 | 2012 | 23 | |
| 12 | 2018 | 16 | |
| 13 | 2023 | 13 | |
| 14 | 2015 | 12 | |
| 15 | 2018 | 10 | |
| 16 | 2020 | 9 | |
| 17 | 2018 | 9 | |
| 18 | 2017 | 9 | |
| 19 | 2015 | 6 | |
| 20 | 2013 | 6 |
About Gary A. Cameron
Gary A. Cameron is a scholar working on Pharmacology, Molecular Biology, Infectious Diseases, Cellular and Molecular Neuroscience and Oncology, having authored 26 papers that have together received 733 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (4 papers), Antifungal resistance and susceptibility (3 papers), Inflammatory mediators and NSAID effects (3 papers), Liver physiology and pathology (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Redox biology and oxidative stress (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (102 citations), Pharmacology (223 citations), Hepatology (58 citations), Biological Psychiatry (17 citations) and Cellular and Molecular Neuroscience (90 citations). Gary A. Cameron has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Lorna Aucott, Nigel R. Webster, Helen F. Galley, Damon A. Lowes, Gabrielle Hawksworth, James S. McLay, Lucy J. Elrick, Matthew C. Wright, Carylyn J. Marek and Giuseppe Tortoriello. Their work appears in journals such as PLoS ONE, Toxicology, Nature Communications, Pharmaceutics and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.